Related Experiment Video
Updated: Jul 13, 2026

Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition
Published on: March 3, 2023
Inhibition of nitric oxide-induced apoptosis by nicotine in oral epithelial cells
Abhijit G Banerjee1, Velliyur K Gopalakrishnan, Jamboor K Vishwanatha
1Department of Oral Biology, Dental Diagnostic and Surgical Sciences, University of Manitoba, Health Science Center Campus, Winnipeg, MB, Canada, R3E0W2. banerjea@cc.umanitoba.ca
Abstract:
Development of oral cancer is clearly linked to the usage of smokeless tobacco. The molecular mechanisms involved in this process are however not well understood. Toward this goal, we investigated the effect of smokeless tobacco exposure on apoptosis of oral epithelial cells. Exposure of oral epithelial cells to smokeless tobacco extract (STE) induces apoptosis in a dose-dependent manner, until a threshold level of nicotine is achieved upon which apoptosis is inhibited. 1 mM of nicotine is able to inhibit apoptosis significantly induced by STE in these oral cells. Exposure of cells to nicotine alone has no effect on apoptosis, but nicotine inhibits apoptosis induced by other agents present in STE. In this study we show that, the anti-apoptotic action of nicotine is specifically associated with down-regulation of nitric oxide (NO) production. Using specific inducers of NO, we have demonstrated that inhibition of apoptosis by nicotine is through down-regulation of NO production. Further, we observed that nicotine clearly acts as a sink of NO radicals, shown using peroxynitrite generator (SIN-1) in conjunction or absence of radical scavengers. Nicotine thus causes most damage in transformed epithelial cells as depicted by accumulation of nitrotyrosine in a 3-NT ELISA assay. Inhibition of apoptosis is a hallmark in tumor progression and propels development of cancer. It may further result in functional loss of apoptotic effector mechanisms in the transformed cells. Thus, our data clearly indicates that inhibition of NO-induced apoptosis by nicotine may lead to tobacco-induced oral carcinogenesis, and implies careful development of modalities in tobacco cessation programs.
Insights
Smokeless tobacco use contributes to oral cancer by inhibiting apoptosis, programmed cell death, through nicotine
Area of Science:
- Oncology
- Molecular Biology
- Toxicology
Background:
- Smokeless tobacco use is a significant risk factor for oral cancer.
- The precise molecular mechanisms driving smokeless tobacco-induced oral carcinogenesis remain unclear.
- Understanding apoptosis regulation in oral epithelial cells is crucial for cancer prevention strategies.
Purpose of the Study:
- To investigate the impact of smokeless tobacco exposure on oral epithelial cell apoptosis.
- To elucidate the role of nicotine and nitric oxide (NO) in smokeless tobacco-induced apoptosis.
- To explore the potential link between nicotine's anti-apoptotic effects and oral cancer development.
Main Methods:
- Exposure of oral epithelial cells to smokeless tobacco extract (STE) and varying nicotine concentrations.
- Assessment of apoptosis using cell viability assays and detection of apoptotic markers.
- Measurement of nitric oxide (NO) production and radical scavenging activity.
- Analysis of nitrotyrosine accumulation in transformed cells using 3-NT ELISA.
Main Results:
- STE induced apoptosis in oral epithelial cells in a dose-dependent manner.
- Nicotine inhibited STE-induced apoptosis at concentrations of 1 mM and above.
- Nicotine's anti-apoptotic effect was linked to the down-regulation of nitric oxide (NO) production.
- Nicotine acted as a sink for NO radicals, leading to increased nitrotyrosine in transformed cells.
Conclusions:
- Nicotine's inhibition of NO-induced apoptosis may contribute to smokeless tobacco-associated oral carcinogenesis.
- The anti-apoptotic action of nicotine highlights a critical mechanism in tobacco-induced cancer.
- Findings suggest the need for targeted strategies in tobacco cessation programs to address nicotine's role in cancer progression.
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Nitric Oxide Signaling Pathway
2° Amines to N-Nitrosamines: Reaction with NaNO2
